Compass Therapeutics Inc (CMPX)

12:34 PM

Raymond James reiterates Compass Therapeutics stock Outperform rating - Investing.com

12:34 PM

11:46 AM

Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update - Investing News Network

11:46 AM

11:17 AM

Compass Therapeutics (NASDAQ:CMPX) Releases Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

11:17 AM

08:06 AM

Compass Therapeutics' Q4 Net Loss Narrows - marketscreener.com

08:06 AM

07:49 AM

Earnings Flash (CMPX) Compass Therapeutics Posts Q4 Net Loss $0.09 a Share, vs. FactSet Est of $0.09 Loss - marketscreener.com

07:49 AM

07:37 AM

Compass Therapeutics' 2025 net loss widens as R&D costs jump - TradingView

07:37 AM

07:35 AM

Compass Therapeutics 10-K: $0.0M Revenue, $(0.42) EPS on $(66.5)M Net Loss - TradingView

07:35 AM

Mar 04, 2026

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com

Mar 04, 2026

Mar 03, 2026

Assessing Compass Therapeutics (CMPX) Valuation As CTX-009 Gains Attention In Biliary Tract Cancer Market - Yahoo Finance

Mar 03, 2026

Mar 03, 2026

Monashee Investment Management Boosts Stake in Compass Therapeutics - National Today

Mar 03, 2026

Mar 02, 2026

Signal Recap: Does Compass Therapeutics Inc have a competitive edgeQuarterly Performance Summary & Real-Time Chart Pattern Alerts - baoquankhu1.vn

Mar 02, 2026

Mar 01, 2026

Monashee Investment Management LLC Has $4.38 Million Stake in Compass Therapeutics, Inc. $CMPX - MarketBeat

Mar 01, 2026

Feb 26, 2026

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Exploring a 130% Potential Upside in Biotech - DirectorsTalk Interviews

Feb 26, 2026

Feb 26, 2026

Compass Therapeutics earnings on deck as pivotal cancer data looms By Investing.com - Investing.com Canada

Feb 26, 2026

Feb 26, 2026

Compass Therapeutics earnings on deck as pivotal cancer data looms - Investing.com

Feb 26, 2026

Feb 23, 2026

Compass Therapeutics Inc. expected to post a loss of 9 cents a shareEarnings Preview - TradingView

Feb 23, 2026

Feb 21, 2026

Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Feb 21, 2026

Feb 20, 2026

Zacks.com Spotlights Orla Mining, FIGS, and Compass Therapeutics - Intellectia AI

Feb 20, 2026

Feb 20, 2026

Is Compass Therapeutics Inc. stock forming a cup and handleJuly 2025 Retail & Reliable Entry Point Trade Alerts - mfd.ru

Feb 20, 2026

Feb 20, 2026

Compass Therapeutics Moves CTX-10726 Into the Clinic: What Early Investors Should Know - TipRanks

Feb 20, 2026

Feb 19, 2026

Compass Therapeutics (CMPX) to Release Quarterly Earnings on Thursday - MarketBeat

Feb 19, 2026

Feb 17, 2026

Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Feb 17, 2026

Feb 16, 2026

Support Test: Can Compass Therapeutics Inc. sustain its profitabilityOil Prices & Weekly Return Optimization Alerts - mfd.ru

Feb 16, 2026

Feb 16, 2026

Bearish Setup: Will Compass Therapeutics Inc stock go up in YEAREarnings Miss & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn

Feb 16, 2026

Feb 16, 2026

Compass Therapeutics (NASDAQ:CMPX) Raised to "Hold" at Wall Street Zen - MarketBeat

Feb 16, 2026

Feb 16, 2026

Compass Therapeutics (NASDAQ:CMPX) Research Coverage Started at Craig Hallum - Defense World

Feb 16, 2026

Feb 16, 2026

Compass Therapeutics (NASDAQ:CMPX) Raised to “Hold” at Wall Street Zen - Defense World

Feb 16, 2026

Feb 14, 2026

How much upside does Compass Therapeutics Inc. haveWall Street Watch & Daily Stock Momentum Reports - mfd.ru

Feb 14, 2026

Feb 13, 2026

Craig-Hallum initiates coverage on Compass Therapeutics stock with Buy rating - Investing.com Canada

Feb 13, 2026

Feb 13, 2026

Compass Therapeutics stock rises after Craig-Hallum initiates coverage with Buy - Investing.com Canada

Feb 13, 2026

Feb 13, 2026

Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Craig Hallum - MarketBeat

Feb 13, 2026

Feb 12, 2026

Compass Therapeutics, Inc. (CMPX) Stock Analysis: A Biotech With 109% Potential Upside - DirectorsTalk Interviews

Feb 12, 2026

Feb 12, 2026

Will Compass Therapeutics Inc. outperform during market ralliesJuly 2025 Institutional & Entry Point Confirmation Signals - mfd.ru

Feb 12, 2026

Feb 08, 2026

Compass Therapeutics (NASDAQ:CMPX) Cut to "Sell" at Wall Street Zen - MarketBeat

Feb 08, 2026

Feb 08, 2026

Compass Therapeutics (NASDAQ:CMPX) Cut to “Sell” at Wall Street Zen - Defense World

Feb 08, 2026

Feb 05, 2026

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Evaluating the 112.66% Potential Upside - DirectorsTalk Interviews

Feb 05, 2026

Feb 04, 2026

Canaccord Genuity raises Compass Therapeutics stock price target on Phase 2/3 data expectations - Investing.com Canada

Feb 04, 2026

Feb 03, 2026

Compass Therapeutics (NASDAQ:CMPX) Sets New 1-Year HighHere's What Happened - MarketBeat

Feb 03, 2026

Feb 02, 2026

Compass Therapeutics stock hits 52-week high at 6.51 USD By Investing.com - Investing.com Nigeria

Feb 02, 2026

Feb 02, 2026

Compass Therapeutics stock hits 52-week high at 6.51 USD - Investing.com

Feb 02, 2026

Jan 31, 2026

Wall Street Zen Upgrades Compass Therapeutics (NASDAQ:CMPX) to "Hold" - MarketBeat

Jan 31, 2026

Jan 28, 2026

Compass Therapeutics (NASDAQ:CMPX) Reaches New 1-Year HighHere's Why - MarketBeat

Jan 28, 2026

Jan 27, 2026

Wall Street Analysts See an 113.73% Upside in Compass Therapeutics, Inc. (CMPX): Can the Stock Really Move This High? - Finviz

Jan 27, 2026

Jan 27, 2026

Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Jan 27, 2026